| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 感染控制解决方案(元) | - | - | 310,599,106.51 | 756,129,198.28 | 424,255,211.17 |
| 呼吸治疗解决方案(元) | 1,673,850,989.99 | 2,597,478,982.73 | 1,641,731,966.94 | 3,371,243,855.78 | 2,308,325,460.68 |
| 急救(元) | - | - | 107,777,404.93 | 163,497,222.05 | 80,034,541.48 |
| 家用类电子检测及体外诊断(元) | - | - | 934,550,728.31 | 1,673,717,540.18 | 1,067,929,709.16 |
| 康复及临床器械(元) | - | - | 729,753,486.44 | 1,227,903,924.54 | 708,067,995.76 |
| 糖尿病护理解决方案(元) | - | - | 562,034,137.61 | 726,428,651.51 | 362,752,486.50 |
| 家用健康检测解决方案(元) | 1,014,048,888.37 | 1,563,946,751.60 | - | - | - |
| 临床器械及康复解决方案(元) | 1,134,340,475.49 | 2,092,566,484.83 | - | - | - |
| 血糖管理及POCT解决方案(元) | 674,451,554.69 | 1,029,890,212.41 | - | - | - |
| 急救解决方案及其他(元) | 136,099,338.84 | 239,033,983.48 | - | - | - |
| 营业成本(元) | |||||
| 感染控制解决方案(元) | - | - | 152,107,489.33 | 379,130,392.91 | 197,981,649.38 |
| 呼吸治疗解决方案(元) | 775,058,810.84 | 1,232,902,441.24 | 786,211,515.99 | 1,479,342,181.48 | 1,054,783,951.83 |
| 急救(元) | - | - | 69,179,308.99 | 110,663,605.10 | 54,280,467.33 |
| 家用类电子检测及体外诊断(元) | - | - | 444,402,414.87 | 794,270,236.32 | 486,038,153.88 |
| 康复及临床器械(元) | - | - | 469,380,966.81 | 812,006,834.49 | 463,293,600.68 |
| 糖尿病护理解决方案(元) | - | - | 223,738,432.32 | 271,076,120.96 | 139,567,922.37 |
| 家用健康检测解决方案(元) | 487,069,901.26 | 735,913,936.43 | - | - | - |
| 临床器械及康复解决方案(元) | 673,060,395.48 | 1,243,626,355.78 | - | - | - |
| 血糖管理及POCT解决方案(元) | 269,175,606.67 | 400,370,653.56 | - | - | - |
| 急救解决方案及其他(元) | 91,316,310.35 | 149,059,010.99 | - | - | - |
| 毛利(元) | |||||
| 感染控制解决方案(元) | - | - | 158,491,617.18 | 376,998,805.37 | 226,273,561.79 |
| 呼吸治疗解决方案(元) | 898,792,179.15 | 1,364,576,541.49 | 855,520,450.95 | 1,891,901,674.30 | 1,253,541,508.85 |
| 急救(元) | - | - | 38,598,095.94 | 52,833,616.95 | 25,754,074.15 |
| 家用类电子检测及体外诊断(元) | - | - | 490,148,313.44 | 879,447,303.86 | 581,891,555.28 |
| 康复及临床器械(元) | - | - | 260,372,519.63 | 415,897,090.05 | 244,774,395.08 |
| 糖尿病护理解决方案(元) | - | - | 338,295,705.29 | 455,352,530.55 | 223,184,564.13 |
| 家用健康检测解决方案(元) | 526,978,987.11 | 828,032,815.17 | - | - | - |
| 临床器械及康复解决方案(元) | 461,280,080.01 | 848,940,129.05 | - | - | - |
| 血糖管理及POCT解决方案(元) | 405,275,948.02 | 629,519,558.85 | - | - | - |
| 急救解决方案及其他(元) | 44,783,028.49 | 89,974,972.49 | - | - | - |
| 毛利率(%) | |||||
| 感染控制解决方案(%) | - | - | 51.03 | 49.86 | 53.33 |
| 呼吸治疗解决方案(%) | 53.70 | 52.53 | 52.11 | 56.12 | 54.31 |
| 急救(%) | - | - | 35.81 | 32.31 | 32.18 |
| 家用类电子检测及体外诊断(%) | - | - | 52.45 | 52.54 | 54.49 |
| 康复及临床器械(%) | - | - | 35.68 | 33.87 | 34.57 |
| 糖尿病护理解决方案(%) | - | - | 60.19 | 62.68 | 61.53 |
| 家用健康检测解决方案(%) | 51.97 | 52.95 | - | - | - |
| 临床器械及康复解决方案(%) | 40.67 | 40.57 | - | - | - |
| 血糖管理及POCT解决方案(%) | 60.09 | 61.12 | - | - | - |
| 急救解决方案及其他(%) | 32.90 | 37.64 | - | - | - |
| 收入构成(%) | |||||
| 感染控制解决方案(%) | - | - | 7.25 | 9.55 | 8.57 |
| 呼吸治疗解决方案(%) | 36.13 | 34.53 | 38.30 | 42.57 | 46.62 |
| 急救(%) | - | - | 2.51 | 2.06 | 1.62 |
| 家用类电子检测及体外诊断(%) | - | - | 21.80 | 21.14 | 21.57 |
| 康复及临床器械(%) | - | - | 17.02 | 15.51 | 14.30 |
| 糖尿病护理解决方案(%) | - | - | 13.11 | 9.17 | 7.33 |
| 家用健康检测解决方案(%) | 21.89 | 20.79 | - | - | - |
| 临床器械及康复解决方案(%) | 24.49 | 27.82 | - | - | - |
| 血糖管理及POCT解决方案(%) | 14.56 | 13.69 | - | - | - |
| 急救解决方案及其他(%) | 2.94 | 3.18 | - | - | - |
| 毛利构成(%) | |||||
| 感染控制解决方案(%) | - | - | 7.40 | 9.26 | 8.85 |
| 呼吸治疗解决方案(%) | 38.46 | 36.28 | 39.95 | 46.46 | 49.05 |
| 急救(%) | - | - | 1.80 | 1.30 | 1.01 |
| 家用类电子检测及体外诊断(%) | - | - | 22.89 | 21.60 | 22.77 |
| 康复及临床器械(%) | - | - | 12.16 | 10.21 | 9.58 |
| 糖尿病护理解决方案(%) | - | - | 15.80 | 11.18 | 8.73 |
| 家用健康检测解决方案(%) | 22.55 | 22.02 | - | - | - |
| 临床器械及康复解决方案(%) | 19.74 | 22.57 | - | - | - |
| 血糖管理及POCT解决方案(%) | 17.34 | 16.74 | - | - | - |
| 急救解决方案及其他(%) | 1.92 | 2.39 | - | - | - |